V. Marsaud

发表

Pro-Invasive Activity of the Hippo Pathway Effectors YAP and TAZ in Cutaneous Melanoma

M. Herlyn, M. Sudol, V. Bataille, 2013, The Journal of investigative dermatology.

Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging.

Gérard Férey, Ruxandra Gref, Pascal Clayette, 2010, Nature materials.

In vitro and in vivo biologic evaluation of long‐circulating biodegradable drug carriers loaded with the pure antiestrogen RU 58668

P. Legrand, J. Renoir, R. Gref, 2003, International journal of cancer.

GLI2 cooperates with ZEB1 for transcriptional repression of CDH1 expression in human melanoma cells

A. Postigo, A. Mauviel, V. Marsaud, 2013, Pigment cell & melanoma research.

Liposomal trichostatin A: therapeutic potential in hormone-dependent and -independent breast cancer xenograft models

V. Nicolas, J. Renoir, J. Vergnaud-Gauduchon, 2011, Hormone molecular biology and clinical investigation.

Chromatin structure of hormono-dependent promoters

H. Richard-Foy, F. Gouilleux, V. Marsaud, 1991, The Journal of Steroid Biochemistry and Molecular Biology.

Squalenoyl nanomedicines as potential therapeutics.

P. Couvreur, L. Cattel, B. Stella, 2006, Nano letters.

Cytotoxicity and cellular uptake of newly synthesized fucoidan-coated nanoparticles.

V. Nicolas, G. Ponchel, C. Vauthier, 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin.

K. Bouchemal, S. Sajeesh, C. Sharma, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Transmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: an original drug delivery pathway.

P. Couvreur, V. Nicolas, C. Dubernet, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Large-scale pan-cancer analysis reveals broad prognostic association between TGF-β ligands, not Hedgehog, and GLI1/2 expression in tumors

N. Elarouci, A. de Reyniès, A. Mauviel, 2020, Scientific reports.

Large-scale pan-cancer analysis reveals broad prognostic association between TGF-β ligands, not Hedgehog, and GLI1/2 expression in tumors

N. Elarouci, A. de Reyniès, A. Mauviel, 2019, Scientific Reports.

Biological characterization of folic acid-conjugated poly(H2NPEGCA-co-HDCA) nanoparticles in cellular models

P. Couvreur, G. Géraud, L. Cattel, 2007, Journal of drug targeting.

Antiproliferative and apoptotic activities of tosylcyclonovobiocic acids as potent heat shock protein 90 inhibitors in human cancer cells.

J. Renoir, C. Radanyi, M. Catelli, 2009, Cancer letters.

Synthesis and biological activity of simplified denoviose-coumarins related to novobiocin as potent inhibitors of heat-shock protein 90 (hsp90).

J. Renoir, C. Radanyi, V. Marsaud, 2008, Bioorganic & medicinal chemistry letters.

Encapsulation of gemcitabine lipophilic derivatives into polycyanoacrylate nanospheres and nanocapsules.

P. Couvreur, L. Cattel, S. Arpicco, 2007, International journal of pharmaceutics.

Liposomes loaded with histone deacetylase inhibitors for breast cancer therapy.

S. Lesieur, E. Fattal, J. Renoir, 2010, International journal of pharmaceutics.

Pure antiestrogen RU 58668-loaded nanospheres: morphology, cell activity and toxicity studies.

P. Legrand, J. Renoir, R. Gref, 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Pure antiestrogen‐induced G1‐arrest in myeloma cells results from the reduced kinase activity of cyclin D3/CDK6 complexes whereas apoptosis is mediated by endoplasmic reticulum‐dependent caspases

B. Sola, J. Renoir, V. Marsaud, 2008, International journal of cancer.

Extracellular-protein-enhanced cellular uptake of squalenoyl gemcitabine from nanoassemblies

P. Couvreur, C. Dubernet, D. Desmaële, 2010 .

Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.

E. Baulieu, S. Mader, J. Renoir, 1998, Molecular endocrinology.

Interaction of an amphiphilic squalenoyl prodrug of gemcitabine with cellular membranes.

P. Couvreur, F. Meneau, S. Wack, 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Spironolactone, an aldosterone antagonist, acts as an antiglucocorticosteroid on the mouse mammary tumor virus promoter.

E. Baulieu, H. Richard-Foy, M. Rafestin-Oblin, 1992, Endocrinology.

Establishment of an in vitro model expressing the folate receptor for the investigation of targeted delivery systems

P. Couvreur, P. Colombo, B. Stella, 2005 .

4-Hydroxytamoxifen Inhibits Proliferation of Multiple Myeloma Cells In vitro through Down-Regulation of c-Myc, Up-Regulation of p27Kip1, and Modulation of Bcl-2 Family Members

F. Gouilleux, B. Sola, J. Renoir, 2005, Clinical Cancer Research.

Nanoparticles loaded with ferrocenyl tamoxifen derivatives for breast cancer treatment.

A. Vessières, G. Jaouen, P. Pigeon, 2008, International journal of pharmaceutics.

The transcriptionally-active MMTV promoter is depleted of histone H1.

H. Richard-Foy, M. Bustin, G. Hager, 1992, Nucleic acids research.

Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells.

L. Cattel, S. Arpicco, E. Fattal, 2009, Molecular pharmaceutics.

Formulation of glycerolipidic prodrugs into PEGylated liposomes for brain delivery

P. Couvreur, V. Nicolas, N. Tsapis, 2009 .

New novobiocin analogues as antiproliferative agents in breast cancer cells and potential inhibitors of heat shock protein 90.

B. Stella, J. Renoir, C. Radanyi, 2007, Journal of medicinal chemistry.

The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agent.

S. L. Bridal, D. Jaillard, V. Nicolas, 2010, Biomaterials.

Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells.

Claus-Michael Lehr, Elias Fattal, Silvia Arpicco, 2009, Oligonucleotides.

Improved anti-tumoral capacity of mixed and pure anti-oestrogens in breast cancer cell xenografts after their administration by entrapment in colloidal nanosystems

P. Opolon, E. Connault, B. Stella, 2006, The Journal of Steroid Biochemistry and Molecular Biology.

New Molecular Therapeutic Interventions: The Case of Breast Cancers

J. Renoir, V. Marsaud, 2010 .

Physicochemical characteristics and preliminary in vivo biological evaluation of nanocapsules loaded with siRNA targeting estrogen receptor alpha.

P. Opolon, E. Connault, P. Couvreur, 2008, Biomacromolecules.

Antioestrogen-mediated cell cycle arrest and apoptosis induction in breast cancer and multiple myeloma cells.

B. Sola, J. Renoir, Jack-Michel Renoir, 2008, Journal of molecular endocrinology.

Transcriptional repression of the tyrosinase-related protein 2 gene by transforming growth factor-β and the Kruppel-like transcription factor GLI2.

A. Mauviel, V. Marsaud, D. Javelaud, 2019, Journal of dermatological science.

Expression of Microphthalmia-associated Transcription Factor (MITF), Which Is Critical for Melanoma Progression, Is Inhibited by Both Transcription Factor GLI2 and Transforming Growth Factor-β*

A. Mauviel, V. Marsaud, D. Javelaud, 2012, The Journal of Biological Chemistry.

Dexamethasone and triamcinolone acetonide accumulation in mouse fibroblasts is differently modulated by the immunosuppressants cyclosporin A, FK506, rapamycin and their analogues, as well as by other P-glycoprotein ligands

J. Renoir, D. Fortin, S. L. Bihan, 1998, The Journal of Steroid Biochemistry and Molecular Biology.

Open Access Research

D. Dembélé, P. Hernon, Candy Schwartz, 2022 .

Systemic Magnetic Targeting of Pure-Antiestrogen-Loaded Superparamagnetic Nanovesicles for Effective Therapy of Hormone- Dependent Breast Cancers

S. Lesieur, C. Ménager, O. Clément, 2013 .

Estrogen receptor signaling as a target for novel breast cancer therapeutics.

J. Renoir, Jack-Michel Renoir, Véronique Marsaud, 2013, Biochemical pharmacology.

Chromatin structure and dynamics: functional implications.

V. Morales, H. Richard-Foy, V. Marsaud, 2001, Biochimie.

RU49953: a non-hormonal steroid derivative that potently inhibits P-glycoprotein and reverts cellular multidrug resistance

J. M. Pérez-Victoria, A. di Pietro, S. Castanys, 2003, Cellular and Molecular Life Sciences CMLS.

Alternative cyclin D1 forms a and b have different biological functions in the cell cycle of B lymphocytes.

B. Sola, J. Renoir, V. Marsaud, 2007, Experimental cell research.

Cyclin K and cyclin D1b are oncogenic in myeloma cells

D. Dembélé, B. Sola, J. Wdzieczak‐Bakala, 2010, Molecular Cancer.

GLI1/GLI2 functional interplay is required to control Hedgehog/GLI targets gene expression.

Sherine F. Elsawa, R. Graham, R. Vera, 2020, The Biochemical journal.

Polyester-Poly(Ethylene Glycol) Nanoparticles Loaded with the Pure Antiestrogen RU 58668: Physicochemical and Opsonization Properties

P. Legrand, G. Barratt, J. Renoir, 2003, Pharmaceutical Research.

Improved antitumoral properties of pure antiestrogen RU 58668-loaded liposomes in multiple myeloma

P. Opolon, E. Connault, F. Gouilleux, 2006, The Journal of Steroid Biochemistry and Molecular Biology.

Thermal enhancement of oxaliplatin-induced inhibition of cell proliferation and cell cycle progression in human carcinoma cell lines

R. Rouzier, D. Atallah, J. Renoir, 2004, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Antiestrogen-binding site ligands induce autophagy in myeloma cells that proceeds through alteration of cholesterol metabolism

B. Sola, M. Poirot, S. Silvente-Poirot, 2013, Oncotarget.

Design of fluorescently tagged poly(alkyl cyanoacrylate) nanoparticles for human brain endothelial cell imaging.

P. Couvreur, P. Couraud, B. Le Droumaguet, 2010, Chemical communications.

Various Phosphorylation Pathways, Depending on Agonist and Antagonist Binding to Endogenous Estrogen Receptor α (ERα), Differentially Affect ERα Extractability, Proteasome-Mediated Stability, and Transcriptional Activity in Human Breast Cancer Cells

Angélique Gougelet, J. Renoir, V. Marsaud, 2003 .

Coadministration of nanosystems of short silencing RNAs targeting oestrogen receptor α and anti-oestrogen synergistically induces tumour growth inhibition in human breast cancer xenografts

P. Opolon, O. Bawa, V. Nicolas, 2010, Breast Cancer Research and Treatment.

Colloidal Systems for the Delivery of Anticancer Agents in Breast Cancer and Multiple Myeloma

B. Sola, E. Fattal, J. Renoir, 2007 .

Drug delivery systems for oestrogenic hormones and antagonists: the need for selective targeting in estradiol-dependent cancers

P. Legrand, J. Renoir, V. Marsaud, 2004, The Journal of Steroid Biochemistry and Molecular Biology.

Cell density sensing alters TGF-β signaling in a cell-type-specific manner, independent from Hippo pathway activation.

A. Mauviel, E. Leof, S. Ben Mimoun, 2015, Developmental cell.

Matters Arising Cell Density Sensing Alters TGF-b Signaling in a Cell-Type-Specific Manner , Independent from Hippo Pathway Activation Highlights

A. Mauviel, E. Leof, F. Nallet-staub, 2015 .

Steroid Transactivation at a Promoter Organized in a Specifically-Positioned Array of Nucleosomes

H. Richard-Foy, G. Hager, M. Cordingley, 1989 .

HIF-1α and rapamycin act as gerosuppressant in multiple myeloma cells upon genotoxic stress

W. Ritchie, B. Sola, J. Cahu, 2016, Cell cycle.

Estrogen receptor α and β subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells

S. O. Mueller, K. Korach, Angélique Gougelet, 2005, The Journal of Steroid Biochemistry and Molecular Biology.

Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestrogen formulation.

R. Gurny, P. Couvreur, M. Besnard, 2001, International journal of pharmaceutics.

Formulation of Didanosine Prodrugs into PEGylated Poly(alkyl cyanoacrylate) Nanoparticles and Uptake by Brain Endothelial Cells

P. Couvreur, V. Nicolas, J. Nicolas, 2009 .

Anticancer efficacy of squalenoyl gemcitabine nanomedicine on 60 human tumor cell panel and on experimental tumor.

P. Couvreur, J. Renoir, D. Desmaële, 2009, Molecular pharmaceutics.

Anticancer drugs in liposomal nanodevices: a target delivery for a targeted therapy.

J. Renoir, V. Marsaud, Giorgia Urbinati, 2012, Current topics in medicinal chemistry.

Therapeutic Potential of New 4-hydroxy-tamoxifen-Loaded pH-gradient Liposomes in a Multiple Myeloma Experimental Model

Elias Fattal, Silvia Arpicco, B. Sola, 2010, Pharmaceutical Research.

PEGylation and preliminary biocompatibility evaluation of magnetite-silica nanocomposites obtained by high energy ball milling.

K. Bouchemal, C. Dubernet, J. Nicolas, 2010, International journal of pharmaceutics.

Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.

Angélique Gougelet, J. Renoir, V. Marsaud, 2003, Molecular endocrinology.

Anti‐Estrogen‐Loaded Superparamagnetic Liposomes for Intracellular Magnetic Targeting and Treatment of Breast Cancer Tumors

S. Lesieur, C. Ménager, C. Wilhelm, 2011 .

Abstract LB-028: Cell density sensing alters TGF-beta signaling in a cell type-specific manner, independent from Hippo pathway activation

A. Mauviel, E. Leof, F. Nallet-staub, 2015 .

Open Access RESEARCH

A. Noor, J. Vulule, D. Dembélé, 2010 .

Innovative drug delivery nanosystems improve the anti-tumor activity in vitro and in vivo of anti-estrogens in human breast cancer and multiple myeloma

F. Gouilleux, B. Sola, E. Fattal, 2005, The Journal of Steroid Biochemistry and Molecular Biology.

Open Access RESEARCH

D. Dembélé, L. Traber, D. Traber, 2010 .

Open Access RESEARCH

W. Takken, B. Knols, D. Dembélé, 2010 .

Open Access RESEARCH

A. W. den Hartog, D. Dembélé, J. Binnekade, 2010 .

Estrogen receptor signaling as a target for novel breast cancer therapeutics.

J. Renoir, V. Marsaud, G. Lazennec, 2013, Biochemical pharmacology.

Liposomal trichostatin A: therapeutic potential in hormone-dependent and -independent breast cancer xenograft models

V. Nicolas, J. Renoir, J. Vergnaud-Gauduchon, 2011, Hormone molecular biology and clinical investigation.

Estrogen Receptor Signaling as a Target for Novel Breast Cancer Therapeutics Running Title: New Targets in Estradiol Receptor-positive Breast Cancers

J. Renoir, V. Marsaud, G. Lazennec, 2012 .

Cytotoxicity and cellular uptake of newly synthesized fucoidan-coated nanoparticles.

V. Marsaud, N. Santos-Magalhães, M. Lira, 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

B. Sola, J. Renoir, V. Marsaud, 2008, International journal of cancer.

4-Hydroxy-tamoxifen-loaded liposomes have potent anti-myeloma activity

B. Sola, J. Renoir, V. Marsaud, 2013, Leukemia & lymphoma.

Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.

S. O. Mueller, K. Korach, Angélique Gougelet, 2005, The Journal of steroid biochemistry and molecular biology.